Wordt geladen...
Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner
Glioblastoma is associated with a poor overall survival despite new treatment advances. Antiangiogenic strategies targeting VEGF based on tyrosine kinase inhibitors (TKIs) are currently undergoing extensive research for the treatment of glioma. Herein we demonstrated that the TKI axitinib induces DN...
Bewaard in:
Gepubliceerd in: | Oncotarget |
---|---|
Hoofdauteurs: | , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Impact Journals LLC
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5356889/ https://ncbi.nlm.nih.gov/pubmed/27926485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13769 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|